Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berinert for ACE-Induced Angioedema
NCT01843530Phase 3Completed
- Sponsor
- Technical University of Munich
- Start
- Nov 2013
- Primary completion
- Oct 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of c1-esterase inhibitor in angioedema, sponsored by Technical University of Munich. Started Nov 2013; status: completed.
02
Drugs
c1-esterase inhibitor
03
Conditions
angioedema
Beyond the preview
Go deeper on NCT01843530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01843530.